Effects of breast cancer treatment on the hormonal and cognitive consequences of acute stress

Psycho-Oncology

Volumn 21, Issue 10, 2012, Pages 1091-1098

  Andreano, Joseph M ^a   Waisman, James ^b,c   Donley, Lisa ^c   Cahill, Larry ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b LONG BEACH MEMORIAL MEDICAL CENTER   (United States)

^c Breastlink Medical Group   (United States)

Author keywords

cancer; endocrinology; Lupron; memory; oncology

Indexed keywords

GLUCOCORTICOID; HYDROCORTISONE; LEUPRORELIN; TAMOXIFEN;

ACUTE STRESS; ADULT; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER SURVIVOR; CLINICAL ARTICLE; COGNITION; COGNITIVE DEFECT; CONTROLLED STUDY; FEMALE; HUMAN; HYDROCORTISONE BLOOD LEVEL; HYDROCORTISONE RELEASE; NARRATIVE; OVARY DISEASE; RECALL; WORKING MEMORY;

ANTINEOPLASTIC AGENTS, HORMONAL; BREAST NEOPLASMS; CASE-CONTROL STUDIES; COGNITION; COGNITION DISORDERS; FEMALE; HUMANS; HYDROCORTISONE; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LEUPROLIDE; MEMORY; NEUROPSYCHOLOGICAL TESTS; PITUITARY-ADRENAL SYSTEM; SALIVA; STRESS, PSYCHOLOGICAL; SURVIVORS;

EID: 84867210932     PISSN: 10579249     EISSN: 10991611     Source Type: Journal    
DOI: 10.1002/pon.2006     Document Type: Article

References (51)

1. Ahles TA, Saykin AJ, Furstenberg CT, et al,. Neuropsychologic impact of standard dose systemic chemotherapy in long-term survivors of breast cancer and lymphoma. J Clin Oncol 2002; 20: 485-493.
2. Brezden CB, Phillips KA, Abdolell M, Bunston T, Tannock IF,. Cognitive function in breast cancer patients receiving adjuvant chemotherapy. J Clin Oncol 2000; 18: 2695-2701.
3. Castellon SA, Ganz PA, Bower JE, Petersen L, Abraham L, Greendale GA,. Neurocognitive performance in breast cancer survivors exposed to adjuvant chemotherapy and tamoxifen. J Clin Exp Neuropsychol 2004; 26 (7): 955-969.
4. Schagen SB, van Dam FS, Muller MJ, Boogerd W, Lindeboom J, Bruning PF,. Cognitive deficits after postoperative adjuvant chemotherapy for breast carcinoma. Cancer 1999; 85 (3): 640-650.
5. Tchen N, Juffs HG, Downie FP, et al,. Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer. J Clin Oncol 2003; 21: 4175-4183.
6. Wieneke MH, Dienst ER,. Neuropsychological assessment of cognitive functioning following chemotherapy for breast cancer. Psycho-Oncology 1995; 4: 61-66.
7. Shilling V, Jenkins V,. Self-reported cognitive problems in women receiving adjuvant therapy for breast cancer. Eur J Oncol Nurs 2007; 11 (1): 6-15.
8. Falleti MG, Sanfilippo A, Maruff P, Weih L, Phillips KA,. The nature and severity of cognitive impairment associated with adjuvant chemotherapy in women with early breast cancer: five year observational cohort study. Br Med J 2005; 330: 702-705.
9. Stewart A, Bielajew C, Collins B, Parkinson M, Tomiak E,. A meta-analysis of the neuropsychological effects of adjuvant chemotherapy treatment in women treated for breast cancer. Clin Neuropsychol 2006; 20: 76-89.
10. Bender, CM, Sereika, SM, Berga, SL, et al,. Cognitive impairment associated with adjuvant therapy in breast cancer. Psychooncology 2006; 15 (5): 422-430.
11. Berndt U, Leplow B, Kantelhardt E, Thomssen C,. Cognitive effects of systematic therapy in patients with breast cancer. Breast Care (Basel) 2009; 4 (3): 177-182.
12. Hermelink K, Untch M, Lux MP, et al,. Cognitive functioning during neoadjuvant chemotherapy for breast cancer: results of a prospective, multicenter, longitudinal study. Cancer 2007; 109 (9): 1905-1913.
13. Jenkins V, Shilling V, Deutsch G, et al,. A 3-year prospective study of the effects of adjuvant treatments on cognition in women with early stage breast cancer. Br J Cancer 2006; 94: 828-834.
14. Matsuda T, Takayama T, Tashiro M, Nakamura Y, Ohashi Y, Shimozuma K,. Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients-evaluation of appropriate research design and methodology to measure symptoms. Breast Cancer 2005; 12 (4): 279-287.
15. Palmer JL, Trotter T, Joy AA, Carlson LE,. Cognitive effects of Tamoxifen in pre-menopausal women with breast cancer compared to healthy controls. J Cancer Surviv 2008; 2 (4): 275-282.
16. Bender CM, Sereika SM, Brufsky AM, et al,. Memory impairments with adjuvant anastrozole versus tamoxifen in women with early-stage breast cancer. Menopause 2007; 14 (6): 995-998.
17. Jenkins V, Shilling V, Fallowfield L, Howell A, Hutton S,. Does hormone therapy for the treatment of breast cancer have a detrimental effect on memory and cognition? A pilot study. Psycho-Oncology 2004; 13 (1): 61-66.
18. Bower JE, Ganz P, Aziz N,. Altered cortisol respons to psychologic stress in breast cancer survivors with persistent fatigue. Psychosom Med 2005a; 67: 277-280.
19. Spiegel D, Giese-Davis J, Barr Taylor C, Kramer H,. Stress sensitivity in metastatic breast cancer: Analaysis of hypothalamic-pituitary-adrenal axis function. Psychoneuroendocrinology 2006; 31: 1231-1244.
20. Van der Pompe G, Antoni MH, Heijnen CJ,. Elevated basal cortisol levels and attenuated ACTH and cortisol responses to a behavioral challenge in women with metastatic breast cancer. Psychoneuroendocrinology 1996; 21 (4): 361-374.
21. Roca CA, Schmidt PJ, Altemus M, et al,. Differential menstrual cycle regulation of hypothalamic-pituitary-adrenal axis in women with premenstrual syndrome and controls. J Clin Endocrinol Metab 2003; 88 (7): 3057-3063.
22. Lustyk MK, Olson KC, Gerrish WG, Holder A, Widman L,. Psychophysiological and neuroendocrine responses to laboratory stressors in women: implications of menstrual cycle phase and stressor type. Biol Psychol 2010; 83: 84-92.
23. Tersman Z, Collins A, Eneroth P,. Cardiovascular responses to psychological stressors during the menstrual cycle. Psychosom Med 1991; 53 (2): 185-197.
24. Pico-Alfonso MA, Mastorci F, Ceresini G, et al,. Acute psychosocial and cardiac autonomic response in women: the role of estrogens, corticosteroids, and behavioral coping styles. Psychoneuroendocrinology 2007; 32 (5): 451-463.
25. Pullens MJ, De Vries J, Roukema JA,. Subjective cognitive dysfunction in breast cancer patients: a systematic review. Psycho-Oncology 2010; 19 (11): 1127-1138.
26. LaBar KS, Cabeza R,. Cognitive neuroscience of emotional memory. Nat Rev Neurosci 2006; 7 (1): 54-64.
27. McGaugh JL,. The amygdala modulates the consolidation of memories of emotionally arousing experiences. Annu Rev Neurosci 2004; 27: 1-28.
28. Roozendaal B, Okuda S, Van der Zee EA, McGaugh JL,. Glucocorticoid enhancement of memory requires arousal-induced noradrenergic activation in the basolateral amygdala. Proc Natl Acad Sci USA 2006; 103 (17): 6741-6746.
29. Lupien SJ, Wilkinson CW, Briere S, Menard C, Ng Ying Kin KM, Nair NP,. The modulatory effects of corticosteroids on cognition: studies in young human populations. Psychoneuroendocrinology 2002; 27 (3): 401-406.
30. Maheu FS, Joober R, Lupien SJ,. Declarative memory after stress in humans: differential involvement of the beta-adrenergic and corticosteroid systems. J Clin Endocrinol Metab 2005; 90 (3): 1697-1704.
31. Abercrombie HC, Kalin NH, Thurow ME, Rosenkranz MA, Davidson RJ,. Cortisol variation in humans affects memory for emotionally laden and neutral information. Behav Neurosci 2003; 117: 505-516.
32. Buchanan TW, Lovallo WR,. Enhanced memory for emotional material following stress-level cortisol treatment in humans. Psychoneuroendocrinology 2001; 26: 307-317.
33. Kuhlmann S, Wolf OT,. Arousal and cortisol interact in modulating memory consolidation in healthy young men. Behav Neurosci 2006; 120 (1): 217-223.
34. Andreano JM, Cahill LF,. Glucocorticoid release and memory consolidation in men and women. Psychol Sci 2006; 17 (6): 466-470.
35. Nater UM, Moor C, Okere U, et al,. Performance on a declarative memory task is better in high than low cortisol responders to psychosocial stress. Psychoneuroendocrinology 2007; 32 (6): 758-763.
36. Smeets T, Giesbrecht T, Jelicic M, Merkelbach H,. Context-dependent enhancement of declarative memory performance following acute psychosocial stress. Biol Psychol 2007; 76 (1-2): 116-123.
37. Pruessner JC, Wolf OT, Hellhammer DH, et al,. Free cortisol levels after awakening: a reliable biological marker for the assessment of adrenocortical activity. Life Sci 1997; 61: 2539-2549.
38. Shirtcliff EA, Granger DA, Schwartz E, Curran MJ,. Use of salivary biomarkers in biobehavioral research: cotton-based sample collection methods can interfere with salivary immunoassay results. Psychoneuroendocrinology 2001; 26 (2): 165-731.
39. O'Connor M, Christensen S, Jensen AB, Moller S, Zachariae R,. How traumatic is breast cancer? Post-traumatic stress symptoms (PTSS) and risk factors for severe PTSS at 3 and 15 months after surgery in a nationwide cohort of Danish women treated for primary breast cancer. Br J Cancer 2011; 104 (3): 419-426.
40. Sherwin BB, Tulandi T,. "Add-back" estrogen reverses cognitive deficits induced by a gonadotropin-releasing hormone agonist in women with leiomyomata uteri. J Clin Endocrinol Metab 1996; 81 (7): 2545-2549.
41. Grigorova M, Sherwin BB, Tulandi T,. Effects of treatment with leuprolide acetate depot on working memory and executive functions in young premenopausal women. Psychoneuroendocrinology 2006; 31 (8): 935-947.
42. Bower JE, Ganz P, Dickerson SS, Petersen L, Aziz N, Fahey JL,. Diurnal cortisol rhythm and fatigue in breast cancer survivors. Psychoneuroendocrinology 2005b; 30 (1): 92-100.
43. Giese-Davis J, Wilhelm FH, Conrad A, et al,. Depression and stress reactivity in metastatic breast cancer. Psychosom Med 2006; 68 (5): 675-683.
44. Andreano JM, Cahill L,. Menstrual cycle modulation of the relationship between cortisol and long term memory. Psychoneuroendocrinology 2008; 33 (6): 874-882.
45. Kirschbaum C, Kudielka BM, Gaab J, Schommer NC, Hellhammer DH,. Impact of gender, menstrual cycle phase, and oral contraceptives on the activity of the hypothalamic-pituitary-adrenal axis. Psychosom Med 1999; 61 (2): 154-162.
46. Kudielka BM, Kirschbaum C,. Awakening cortisol responses are influenced by health status and awakening time but not by menstrual cycle phase. Psychoneuroendocrinology 2003; 28 (1): 35-47.
47. Bouma EM, Riese H, Ormel J, Verhulst FC, Oldehinkel AJ,. Adolescents' cortisol responses to awakening and social stress; effects of gender, menstrual phase, and oral contraceptives. The TRAILS study. Psychoneuroendocrinology 2009; 34 (6): 884-893.
48. Altemus M, Roca C, Galliven E, Romanos C, Deuster P,. Increased vasopressin and adrenocorticotropin responses to stress in the midluteal phase of the cycle. J Clin Endocrinol Metab 2001; 86 (6): 2525-2530.
49. Abercrombie HC, Speck NS, Monticelli RM,. Endogenous cortisol elevations are related to memory facilitation only in individuals who are emotionally aroused. Psychoneuroendocrinology 2006; 31 (2): 187-196.
50. Cahill L, Gorski L, Le K,. Enhanced human memory consolidation with post-learning stress: interaction with the degree of arousal at encoding. Learn Mem 2003; 10 (4): 270-274.
51. Domes G, Rothfischer J, Reichwald U, Hautzinger M,. Inverted-U function between salivary cortisol and retrieval of verbal memory after hydrocortisone treatment. Behav Neurosci 2005; 119 (2): 512-517.